Pfizer and Valneva are partnering on a Lyme vaccine and are currently seeking necessary approval from the FDA.
2 reports, 2 independent
Updated Thu 00:00
No new developments lately
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer and Valneva are partnering on a Lyme vaccine and are currently seeking necessary approval from the FDA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- FDA granted approval for Pfizer's updated vaccine on September 2, 2025.
- The EMA has validated the Marketing Authorization Application (MAA) for a vaccine developed in collaboration between Valneva and Pfizer.
- FDA approval precedes CDC sign-off on vaccines, and the Secretary appointed members to the CDC advisory committee.
- Moderna and Merck are developing cancer vaccines in partnership, while Moderna is also seeking approval for its seasonal influenza vaccine.
- FDA approved new COVID booster vaccines, with major medical groups like AAP and AMA offering support and facing political pressure regarding their guidance.